blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3722437

EP3722437 - VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  24.12.2021
Database last updated on 09.04.2026
FormerRequest for examination was made
Status updated on  16.04.2021
FormerThe application has been published
Status updated on  11.09.2020
Most recent event   Tooltip12.03.2026New entry: Renewal fee paid 
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2020/42]
Inventor(s)01 / KOERBELIN, Jakob
Duschweg 16
22769 Hamburg / DE
02 / MICHELFELDER, Stefan
Grüner Weg 1/2
79211 Denzlingen / DE
03 / TREPEL, Martin
Rungholt 29
22149 Hamburg / DE
 [2020/42]
Representative(s)Eisenführ Speiser
Patentanwälte Rechtsanwälte PartGmbB
Johannes-Brahms-Platz 1
20355 Hamburg / DE
[N/P]
Former [2020/42]Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
Application number, filing date20169379.315.04.2015
[2020/42]
Priority number, dateDE20141020749817.04.2014         Original published format: DE102014207498
[2020/42]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP3722437
Date:14.10.2020
Language:DE
[2020/42]
Search report(s)(Supplementary) European search report - dispatched on:EP15.09.2020
ClassificationIPC:C12N15/861, C07K14/005
[2020/42]
CPC:
C07K14/005 (EP,US); C07K7/06 (US); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P43/00 (EP); C12N15/86 (US); C12N7/00 (US);
A61K38/00 (EP,US); A61K48/00 (US); C12N2710/14144 (EP,US);
C12N2750/14122 (EP,US); C12N2750/14133 (US); C12N2750/14143 (EP,US);
C12N2810/6027 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/20]
Former [2020/42]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VIRALER VEKTOR FÜR DEN ZIELGERICHTETEN GENTRANSFER IN GEHIRN UND RÜCKENMARK[2020/42]
English:VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD[2020/42]
French:VECTEUR VIRAL POUR LE TRANSFERT GÉNIQUE CIBLÉ DANS LE CERVEAU ET LA MOELLE ÉPINIÈRE[2020/42]
Examination procedure14.04.2021Examination requested  [2021/20]
14.04.2021Date on which the examining division has become responsible
26.07.2021Amendment by applicant (claims and/or description)
23.12.2021Despatch of a communication from the examining division (Time limit: M06)
26.07.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
05.10.2022Reply to a communication from the examining division
25.10.2023Despatch of a communication from the examining division (Time limit: M06)
08.05.2024Reply to a communication from the examining division
Parent application(s)   TooltipEP15715750.4  / EP3132043
EP19153559.0  / EP3533877
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.05.2024Request for further processing filed
08.05.2024Full payment received (date of receipt of payment)
Request granted
15.05.2024Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
05.10.2022Request for further processing filed
05.10.2022Full payment received (date of receipt of payment)
Request granted
18.10.2022Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
26.07.2021Request for further processing filed
26.07.2021Full payment received (date of receipt of payment)
Request granted
10.08.2021Decision despatched
Fees paidRenewal fee
30.04.2020Renewal fee patent year 03
30.04.2020Renewal fee patent year 04
30.04.2020Renewal fee patent year 05
30.04.2020Renewal fee patent year 06
15.04.2021Renewal fee patent year 07
28.03.2022Renewal fee patent year 08
14.03.2023Renewal fee patent year 09
25.04.2024Renewal fee patent year 10
30.04.2025Renewal fee patent year 11
11.03.2026Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y] WO2010127097  (UNIV PENNSYLVANIA et al.)
 [Y]   DATABASE EMBL [online] 29 December 2008 (2008-12-29), "Talaromyces stipitatus ATCC 10500 phenylacetyl-CoA ligase, putative", XP002740760, retrieved from EBI accession no. EMBL:EED12934 Database accession no. EED12934
 [Y]   BENYHE SANDOR ET AL: "Met-5-enkephalin-Arg-6-Phe-7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain", JOURNAL OF NEUROSCIENCE RESEARCH, vol. 48, no. 3, 1997, pages 249 - 258, XP002740763, ISSN: 0360-4012

DOI:   http://dx.doi.org/10.1002/(SICI)1097-4547(19970501)48:3<249::AID-JNR7>3.0.CO;2-F
 [Y]   MEUNIER J-C ET AL: "ISOLATION AND STRUCTURE OF THE ENDOGENOUS AGONIST OF OPIOID RECEPTOR-LIKE ORL1 RECEPTOR", NATURE, vol. 377, 12 October 1995 (1995-10-12), NATURE PUBLISHING GROUP, UNITED KINGDOM, pages 532 - 535, XP002020240, ISSN: 0028-0836, DOI: 10.1038/377532A0

DOI:   http://dx.doi.org/10.1038/377532a0
 [Y]   ALLARD M ET AL: "Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study", BRAIN RESEARCH, vol. 500, no. 1-2, 23 October 1989 (1989-10-23), ELSEVIER, AMSTERDAM, NL, pages 169 - 176, XP024273370, ISSN: 0006-8993, [retrieved on 19891023], DOI: 10.1016/0006-8993(89)90311-9

DOI:   http://dx.doi.org/10.1016/0006-8993(89)90311-9
 [Y]   IGWE O J ET AL: "SPECIFIC BINDING OF SUBSTANCE P AMINO-TERMINAL HEPTAPEPTIDE SP 1-7 TO MOUSE BRAIN AND SPINAL CORD MEMBRANES", JOURNAL OF NEUROSCIENCE, vol. 10, no. 11, 1990, pages 3653 - 3663, XP002740761, ISSN: 0270-6474
 [Y]   BARTLETT J S ET AL: "SELECTIVE AND RAPID UPTAKE OF ADENO-ASSOCIATED VIRUS TYPE 2 IN BRAIN", HUMAN GENE THERAPY, vol. 9, no. 8, 20 May 1998 (1998-05-20), MARY ANN LIEBERT, NEW YORK ,NY, US, pages 1181 - 1186, XP000857504, ISSN: 1043-0342
by applicantUS2007172460
   SHEVTSOVA ET AL., EXP PHYSIOL., vol. 90, no. 1, 2005, pages 53 - 9
   TENENBAUM ET AL., CURR GENE THER, vol. 3, 2003, pages 545 - 565
   WORK ET AL., MOL THER, vol. 4, 2006, pages 683 - 693
   SHI ET AL., HUM GENE THER, vol. 17, 2006, pages 353 - 361
   MICHELFELDER ET AL., PLOS ONE, vol. 4, no. 4, 2009, pages e5122
   KAPLITT ET AL., LANCET, vol. 369, no. 9579, 2007, pages 2097 - 105
   GRAY ET AL., MOL THER, vol. 18, no. 3, 2010, pages 570 - 8
   GRAY ET AL., HUM GENE THER, vol. 22, no. 9, 2011, pages 1143 - 53
   AEBISCHER ET AL., NAT MED, vol. 2, no. 6, 1996, pages 696 - 9
   MCCOWN ET AL., BRAIN RES, vol. 713, no. 1-2, 1996, pages 99 - 107
   DURING ET AL., GENE THER, vol. 5, no. 6, 1998, pages 820 - 7
   NAGABHUSHAN KALBURGI ET AL., DISCOV MED, vol. 15, no. 81, 2013, pages 111 - 9
   ALONSO ET AL., MOL THER NUCLEIC ACIDS, vol. 2, 2013, pages e73
   SHIBARTLETT, MOL THER, vol. 7, 2003, pages 515 - 525
   LOILER ET AL., GENE THER, vol. 10, 2003, pages 1551 - 1558
   RABINOWITZ ET AL., VIROLOGY, vol. 265, 1999, pages 274 - 285
   WU ET AL., J VIROL, vol. 74, 2000, pages 8635 - 8647
   SHI ET AL., HUM GENE THER, vol. 12, 2001, pages 1697 - 1711
   WARRINGTON ET AL., J VIROL, vol. 78, 2004, pages 6595 - 6609
   GIROD ET AL., NAT MED, vol. 5, 1999, pages 1052 - 1056
   GRIFMAN ET AL., MOL THER, vol. 3, 2001, pages 964 - 975
   KERN ET AL., J VIROL, vol. 77, 2003, pages 11072 - 11081
   RUSSELL ET AL., J VIROL, vol. 72, 1998, pages 309 - 319
   MLLER ET AL., NAT BIOTECHNOL, vol. 21, 2003, pages 1040 - 1046
   WATERKAMP ET AL., J GENE MED, vol. 8, 2006, pages 1307 - 1319
   XIAO ET AL., JOURNAL OF VIROLOGY, vol. 72, 1998, pages 2224 - 2232
   ZOLOTUKHIN ET AL., GENE THER, vol. 6, 1999, pages 973 - 985
   MCCARTY ET AL., GENE THER, vol. 8, 2001, pages 1248 - 1254
   MICHELFELDER ET AL., EXP HEMATOL, vol. 35, 2007, pages 1766 - 1776
   ROHR ET AL., J VIROL METHODS, vol. 127, 2005, pages 40 - 45
   URABE ET AL., HUM GENE THER, vol. 13, 2002, pages 1935 - 1943
   KOHLBRENNER ET AL., MOL THER, vol. 12, 2005, pages 1217 - 1225
   CHEN, MOL THER, vol. 16, 2008, pages 924 - 930
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.